











HALO® - The Colony-Forming Assay Alternative
For more than 4 decades, the developmental and experimental hematology community has used the Colony-Forming Assay (CFA). The CFA is a functional, differentiation assay, in that it detects the functional ability of a specific cell population, stimulated with specific growth factors and/or cytokines to produce colonies of cells that can be identified under the microscope. Since the production and differentiation of cells in the colonies relies on the growth factors and/or cytokines to induce the proliferation process, it is assumed and correctly so, that proliferation has taken place. However, the assay does not directly measure proliferation, because it does not detect a biochemical process that is proliferation dependent. Therefore the CFA is NOT a proliferation assay.
In 2002, HemoGenix® developed the HALO® Platform, a Colony-Forming Assay alternative. Originally designed using similar components to the traditional CFA, including methyl cellulose (MeC), the HALO® Platform does not suffer from the numerous drawbacks inherent in the CFA procedure. The most important drawbacks of the CFA procedure are subjectivity and the complete lack of standardization that does not allow experiments performed from day to day or over longer periods of time, to be compared directly with each other. Since all HALO® Platforms measure changes in intracellular ATP (iATP) as a biochemical marker for the proliferative process, detection is non-subjective because it is instrument-based, and standardized because it uses an external ATP standard.
As a result, virtually any of the studies that have previously employed the CFA procedure, can now be performed using a HALO® Platform to produce results that are non-subjective and fully standardized.
HemoGenix® has developed 2 HALO® Platforms, one that uses methyl cellulose to grow lympho-hematopoietic cells under clonal conditions (HALO®-96 MeC), and one that does not use methyl cellulose, but rather expands cells in suspension culture conditions (HALO®-96 SEC). The following table shows the difference between HALO®-96 MeC and HALO®-96 SEC as colony-forming assay alternatives for research.
| Property | Colony-Forming Assay | HALO®-96 MeC | HALO®-96 SEC |
| Type of assay: | Differentiation | Proliferation / Cytotoxicity - | Proliferation / Cytotoxicity - Apoptosis |
| Validated | No | Yes | Yes |
| Type of culture: | Methyl cellulose | Methyl cellulose | Suspension |
| Cell growth: | Clonal | Clonal | Expansion |
| Parameter measured: | Cell colonies | Intracellular ATP | Intracellular ATP |
| Readout: | Manual / Microscopy | Luminescence / Instrument-based | Luminescence / Instrument-based |
| Subjectivity: | Subjective | Non-subjective | Non-subjective |
| Standardization: | Not standardized | External ATP | External ATP |
| Format | 35mm Petri dishes | 96-well plate | 96-well plate |
| Assay description: | Macro | Mini | Mini |
| Volume of assay: | 1ml | 100µl/well | 100µl/well |
| No. of replicates: | 2-3 | Min. 4 - unlimited | Min. 4 - unlimited |
| Cell incubation time: | 7-14 days | 5-7 days | 4-6 days |
| Turnaround time: | 7-14 days | 5-7 days | 4-6 days |
| Processing time / Readout time: | None / ~10 min/plate | 20 min/plate / <5min/plate | 20 min/plate / <5min/plate |
| Throughput capability: | Low | Medium | Medium - High |
| Training: | 6-12 months | 2 days | 2 days |
Both HALO® Assay Kit Platforms are ideal for research purposes; in fact, HemoGenix® has developed a special product line just for the research scientist. HALO® Research Assay kits are available in the following 96-well plate configurations:
Try HALO® - The Colony-Forming Assay Alternative
without counting colonies
for all your cellular research needs